Affymax, Inc. (AFFY) Stock Price & Analysis
Affymax, Inc. (AFFY) closed at USD 0 on Thursday, October 22, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0; the Oct 22, 2026 session ranged USD 0–0 on volume of 6,000 shares. Market capitalization is $59,984, with a 52-week range of USD 0–0.04 (PNK). Source: Nexqual, retrieved October 24, 2026 at 00:35 UTC.
Also available as compact Markdown for AI agents: nexqual.com/AFFY.md
Key facts (AFFY)
- Analysts: None.
- Total return with dividends: 1Y +77.8% vs S&P 500 +14.0%; 5Y -20.0% vs S&P 500 +76.9%.
Analysts (AFFY)
Consensus None.
Total return (dividends reinvested) (AFFY)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +77.8% | -20.0% |
| S&P 500 (SPY) | +14.0% | +76.9% |
| Per year | +78.4% | -4.4% |
| Volatility (annualized) | 721.2% | 464.6% |
| Max drawdown | -96.2% (Sep 2026→Sep 2026) | -99.6% (May 2022→Jun 2025) |
AFFY analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter (ends Sep 2013) | — | — | — | $0 | — |
| Current fiscal year (ends Dec 2013) | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |
Key Statistics (as of October 24, 2026 at 00:35 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.04 |
| Volume | 6,000 shares |
| Market Cap | $59,984 |
| Exchange | PNK |
Technical Analysis (AFFY)
Nexqual's technical model rates AFFY "SELL" based on 2 bullish and 4 bearish signals across 126 daily candles, as of October 24, 2026 at 00:35 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 31.73 (neutral) |
| vs SMA50 | Below (USD 0.01) |
| MACD | 0 (positive) |
Analyst Ratings (AFFY)
Wall Street analysts rate AFFY "None", per Nexqual as of October 24, 2026 at 00:35 UTC.
| Consensus Rating | None |
|---|
Earnings (AFFY)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2013-03-31 | USD -0.9 vs est -0.66 ▼ miss |
| 2012-12-31 | USD -0.63 vs est -0.61 ▼ miss |
| 2012-09-30 | USD -0.68 vs est -0.71 ▲ beat |
| 2012-06-30 | USD -0.89 vs est -0.67 ▼ miss |
Source: Nexqual, October 24, 2026 at 00:35 UTC.
Financials & Fundamentals (AFFY)
| Total Revenue | $42,000 |
|---|---|
| Revenue Growth (latest quarter, YoY) | -92.00% |
| Gross Margin | +497.62% |
| Operating Margin | -2438.09% |
| Profit Margin | +7300.00% |
| ROE | +111.59% |
| Current Ratio | 20.81 |
| Total Cash | $3.40M |
| Total Debt | $0 |
Source: Nexqual, October 24, 2026 at 00:35 UTC.
Financial Health Score (AFFY)
Nexqual rates Affymax, Inc.'s overall financial health "Mixed" across five dimensions, as of October 24, 2026 at 00:35 UTC.
| Growth | Strong — Revenue +98% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $3M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$8M (TTM) |
| Efficiency | Strong — ROE 112%, ROA -228.9% |
Ownership (AFFY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 37.49M |
| Short % of Float | +38.43% |
Source: Nexqual, October 24, 2026 at 00:35 UTC.
Leadership (AFFY)
Affymax, Inc. is led by Jonathan M. Couchman, CEO, President & Director, per Nexqual as of October 24, 2026 at 00:35 UTC.
| CEO, President & Director | Jonathan M. Couchman |
|---|---|
| CFO & Secretary | Mark G. Thompson |
| Vice President of Intellectual Property & Legal Affairs | Tracy J. Dunn |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Incorpor | USD 303.53 | ▼ 1.39% |
| RYTM | Rhythm Pharmaceuticals, Inc. | USD 89.27 | ▼ 1.79% |
| IOVA | Iovance Biotherapeutics, Inc. | USD 14.09 | ▼ 0.35% |
| PRAX | Praxis Precision Medicines, Inc | USD 252.96 | ▼ 2.3% |
| IONS | Ionis Pharmaceuticals, Inc. | USD 42.93 | ▼ 2.23% |
| AXSM | Axsome Therapeutics, Inc. | USD 145.04 | ▼ 7.07% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 00:35 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt